Although these studies suggest a causal relationship between hepatic NF-κB activation and MAFLD development, the contribution of NF-κB activation to the initiation of hepatic steatosis and the underlying mechanism remains unclear. This evidence concerns the gene NFKB1 and fatty liver disease.